In The News

In The News

Medical Device and Diagnostic Industry | January 16, 2018
Would you rather get a biopsy or a blood test to check for prostate cancer?
Genetic Engineering & Biotechnology News | January 15, 2018
New technology has shown promise for detecting CTE and the approximately 150 protein biomarkers linked to conditions in neurology, oncology, cardiology, inflammation, and infectious disease. Called Simoa™, it is a single-molecule array on a fully automated digital immunoassay platform that detects…
January 12, 2018
Presentation led by Kevin Hrusovsky, President, Chairman and CEO Quanterix Presentation Date: Wednesday, January 10, 2018  
The Wall Street Journal | December 08, 2017
Biomarker-analysis company had raised venture capital from ARCH Venture Partners, Bain
Cheddar.com | December 08, 2017
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share.
Bloomberg Baystate Business | December 08, 2017
Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by Quanterix CEO Kevin Hrusovsky to discuss his company’s IPO and first day of trading

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more